Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 8.608.177.076.05

What is the latest Working Capital/Sales ratio of PIRAMAL PHARMA ?

The latest Working Capital/Sales ratio of PIRAMAL PHARMA is 8.60 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20248.60
Mar20238.17
Mar20227.07
Mar20216.05

How is Working Capital/Sales of PIRAMAL PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 8.6
5.26
Mar2023 8.17
15.56
Mar2022 7.07
16.86
Mar2021 6.05 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Working Capital/Sales ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹31,777.0 Cr -0% -9.8% 53.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,692.0 Cr -5.3% -7.8% 24.1% Stock Analytics
DIVIS LABORATORIES ₹149,215.0 Cr -3.9% -7.9% 51% Stock Analytics
CIPLA ₹115,000.0 Cr -1.9% -6.9% 3.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,616.4 Cr -8.3% -14.9% 0.8% Stock Analytics
ZYDUS LIFESCIENCES ₹93,841.4 Cr -5.7% -4% 23.6% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-0%

-9.8%

53.3%

SENSEX

0.2%

-2.2%

7.7%


You may also like the below Video Courses